Search research articles
Contact Us
Filters
Showing results (91-100 of 168) with videos related to
Page
of 17
Sort By:
Current Topics in Medicinal Chemistry
|
September 18, 2012
Population pharmacokinetic analysis of 5-FU and 5-FDHU in colorectal cancer patients: search for biomarkers associated with gastro-intestinal toxicity
Christian Woloch, Antonello Di Paolo, Hafedh Marouani, et al.
Molecular Cancer Therapeutics
|
December 24, 2005
Response of endothelial cells to a dual tyrosine kinase receptor inhibition combined with irradiation
Alexandre Bozec, Patricia Formento, Joseph Ciccolini, et al.
Anti-Cancer Drugs
|
February 16, 2005
Taxotere-5'-deoxy-5-fluorouridine combination on hormone-refractory human prostate cancer cells
Jean-Louis Fischel, Jean-Marc Ferrero, Patricia Formento, et al.
Pharmaceutical Research
|
February 7, 2013
In vitro and in vivo evaluation of lipofufol, a new triple stealth liposomal formulation of modulated 5-fu: impact on efficacy and toxicity
Raphaelle Fanciullino, Séverine Mollard, Sarah Giacometti, et al.
Cancer Research
|
June 29, 2017
Pharmacokinetics and Pharmacodynamics-Based Mathematical Modeling Identifies an Optimal Protocol for Metronomic Chemotherapy
Joseph Ciccolini, Dominique Barbolosi, Christophe Meille, et al.
International Journal of Pharmaceutics
|
April 8, 2024
Pegylated liposome encapsulating docetaxel using microfluidic mixing technique: Process optimization and results in breast cancer models
Mathilde Dacos, Benoît Immordino, Erwan Diroff, et al.
Clinical Cancer Drugs
|
April 24, 2018
UPFRONT DPD DEFICIENCY DETECTION TO SECURE 5-FU ADMINISTRATION: PART 2- APPLICATION TO HEAD-AND-NECK CANCER PATIENTS
Manon Launay, Joseph Ciccolini, Claire Fournel, et al.
Cancer Research
|
June 16, 2016
Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy
Raphael Serre, Sebastien Benzekry, Laetitia Padovani, et al.
Pharmacogenetics and Genomics
|
April 9, 2015
Lethal toxicity after administration of azacytidine: implication of the cytidine deaminase-deficiency syndrome
Raphaelle Fanciullino, Cedric Mercier, Cindy Serdjebi, et al.
British Journal of Haematology
|
September 11, 2023
Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients
Melanie Donnette, Mourad Hamimed, Joseph Ciccolini, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 168) with videos related to
Sort By:
Page
of 17
Current Topics in Medicinal Chemistry
|
September 18, 2012
Population pharmacokinetic analysis of 5-FU and 5-FDHU in colorectal cancer patients: search for biomarkers associated with gastro-intestinal toxicity
Christian Woloch, Antonello Di Paolo, Hafedh Marouani, et al.
Molecular Cancer Therapeutics
|
December 24, 2005
Response of endothelial cells to a dual tyrosine kinase receptor inhibition combined with irradiation
Alexandre Bozec, Patricia Formento, Joseph Ciccolini, et al.
Anti-Cancer Drugs
|
February 16, 2005
Taxotere-5'-deoxy-5-fluorouridine combination on hormone-refractory human prostate cancer cells
Jean-Louis Fischel, Jean-Marc Ferrero, Patricia Formento, et al.
Pharmaceutical Research
|
February 7, 2013
In vitro and in vivo evaluation of lipofufol, a new triple stealth liposomal formulation of modulated 5-fu: impact on efficacy and toxicity
Raphaelle Fanciullino, Séverine Mollard, Sarah Giacometti, et al.
Cancer Research
|
June 29, 2017
Pharmacokinetics and Pharmacodynamics-Based Mathematical Modeling Identifies an Optimal Protocol for Metronomic Chemotherapy
Joseph Ciccolini, Dominique Barbolosi, Christophe Meille, et al.
International Journal of Pharmaceutics
|
April 8, 2024
Pegylated liposome encapsulating docetaxel using microfluidic mixing technique: Process optimization and results in breast cancer models
Mathilde Dacos, Benoît Immordino, Erwan Diroff, et al.
Clinical Cancer Drugs
|
April 24, 2018
UPFRONT DPD DEFICIENCY DETECTION TO SECURE 5-FU ADMINISTRATION: PART 2- APPLICATION TO HEAD-AND-NECK CANCER PATIENTS
Manon Launay, Joseph Ciccolini, Claire Fournel, et al.
Cancer Research
|
June 16, 2016
Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy
Raphael Serre, Sebastien Benzekry, Laetitia Padovani, et al.
Pharmacogenetics and Genomics
|
April 9, 2015
Lethal toxicity after administration of azacytidine: implication of the cytidine deaminase-deficiency syndrome
Raphaelle Fanciullino, Cedric Mercier, Cindy Serdjebi, et al.
British Journal of Haematology
|
September 11, 2023
Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients
Melanie Donnette, Mourad Hamimed, Joseph Ciccolini, et al.
Page
of 17